SAN DIEGO, Sept. 19 /PRNewswire-FirstCall/ -- Metabasis Therapeutics (Nasdaq: MBRX - News), announced today that Dr. Paul Laikind, president and chief executive officer of Metabasis will present at the UBS Global Life Sciences Conference at the Grand Hyatt Hotel in New York, NY. Dr. Laikind is scheduled to present on Monday, September 25, 2006 at 11:30 a.m. Eastern Time, and is expected to provide an overview of the Company’s progress and discuss product candidates in clinical and pre-clinical development.
